High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549 302. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1 13. 303. CAPRIE Steering Committee. A randomised, blinded, trial of clopido- grel versus aspirin in patients at risk of ischaemic events (CAPRIE): CAPRIE Steering Committee. Lancet. 1996;348:1329 1339. doi: 304. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopido- grel for recurrent stroke. N Engl J Med. 2008;359:1238 1251. doi: 305. SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345 1349. 306. PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033 307. Burke JF, Gelb DJ, Quint DJ, Morgenstern LB, Kerber KA. The impact of MRI on stroke management and outcomes: a systematic review. J Eval Clin Pract. 2013;19:987 993. doi: 10.1111/jep.12011 308. Wardlaw J, Brazzelli M, Miranda H, Chappell F, McNamee P, Scotland G, Quayyum Z, Martin D, Shuler K, Sandercock P, et al. An assessment of the cost-effectiveness of magnetic resonance, including diffusion- weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation. Health Technol Assess. 2014;18:1 368, v vi. doi: 10.3310/hta18270 309. Ertl-Wagner B, Brandt T, Seifart C, Forsting M. Diagnostic and thera- peutic consequences of repeat brain imaging and follow-up vascular im- aging in stroke patients. AJNR Am J Neuroradiol. 1999;20:37 42. 310. 